Position in NEO
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$889,114
+$440,375 QoQ
Shares Held
60,940
+0.8% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#97
of 265 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $21,207,266 across 19 Diagnostics & Research names. NEO ranks #8 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
11,918 | $5,975,208 | |
| 2 | DHR |
Danaher Corp /De/
|
15,391 | $2,931,677 | |
| 3 | LH |
Labcorp Holdings Inc.
|
7,651 | $2,142,280 | |
| 4 | A |
Agilent Technologies, Inc.
|
9,423 | $1,251,657 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,125 | $1,118,685 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
5,581 | $1,078,360 | |
| 7 | ILMN |
Illumina, Inc.
|
5,103 | $897,260 | |
| 8 | NEO |
Neogenomics Inc
This page
|
60,940 | $889,114 |
All Filings in NEO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $889,114 | 60,940 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $448,739 | 60,477 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $722,793 | 61,462 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $464,350 | 60,149 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $268,803 | 36,772 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $379,324 | 39,971 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $691,319 | 41,949 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $619,028 | 41,968 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $565,549 | 40,775 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||